Aim-listed Deltex Medical has lost a third of its value despite announcing a deal with NHS Supply Chain for 60 of its monitors.
The explanation for this seeming anomaly can be found later in the statement. The company warns:
At this stage the company is actively pursuing potential orders from individual NHS Trusts with a collective value in excess of £1 million. If all closed out successfully, these would mean approximately flat UK sales when compared to the 2013 financial year end. In addition, the company is pursuing a tender worth up to £0.3m from a hospital system in Canada which was expected to be announced earlier in December but is now not expected to be awarded until 2015.
To the extent that the above transactions are not completed before 31 December 2014, the company expects its sales for the year to fall below the range of market expectations.
That warning has sent its shares down 33% or 2.375p to 4.75p.
As far as the order for 60 oesophageal Doppler monitors, the company said the deal with NHS Supply Chain, a logistics provider to the health service, is in contrast to the cash restrictions faced by local NHS frontline providers.
